Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections

HJ Morrill, JM Pogue, KS Kaye… - Open forum infectious …, 2015 - academic.oup.com
This article provides a comprehensive review of currently available treatment options for
infections due to carbapenem-resistant Enterobacteriaceae (CRE). Antimicrobial resistance …

Therapeutic options for carbapenem-resistant Enterobacteriaceae infections

EM Trecarichi, M Tumbarello - Virulence, 2017 - Taylor & Francis
In recent years, carbapenem resistance among Enterobacteriaceae has dramatically
increased and represents an important threat to global health. The optimal therapeutic …

[HTML][HTML] Management of carbapenem-resistant Enterobacteriaceae infections

E Durante-Mangoni, R Andini, R Zampino - Clinical Microbiology and …, 2019 - Elsevier
Background Carbapenem resistance is defined as in vitro non-susceptibility to any
carbapenem and/or documented production of a carbapenemase. This feature has rapidly …

Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes

D Van Duin, KS Kaye, EA Neuner… - … microbiology and infectious …, 2013 - Elsevier
The emergence of carbapenem resistance in Enterobacteriaceae is an important threat to
global health. Reported outcomes of infections with carbapenem-resistant …

Infections Caused by Carbapenem-Resistant Enterobacteriaceae: An Update on Therapeutic Options

CC Sheu, YT Chang, SY Lin, YH Chen… - Frontiers in …, 2019 - frontiersin.org
Carbapenems are considered as last-resort antibiotics for the treatment of infections caused
by multidrug-resistant Gram-negative bacteria. With the increasing use of carbapenems in …

Treatment for carbapenem-resistant Enterobacterales infections: recent advances and future directions

K Tompkins, D van Duin - European Journal of Clinical Microbiology & …, 2021 - Springer
Carbapenem-resistant Enterobacterales (CRE) are a growing threat to human health
worldwide. CRE often carry multiple resistance genes that limit treatment options and …

Antibiotic treatment of infections due to carbapenem-resistant Enterobacteriaceae: systematic evaluation of the available evidence

ME Falagas, P Lourida, P Poulikakos… - Antimicrobial agents …, 2014 - Am Soc Microbiol
We sought to evaluate the effectiveness of the antibiotic treatment administered for infections
caused by carbapenemase-producing Enterobacteriaceae. The PubMed and Scopus …

Emerging Carbapenem-Resistant Enterobacteriaceae Infection, Its Epidemiology and Novel Treatment Options: A Review

M Tilahun, Y Kassa, A Gedefie… - Infection and drug …, 2021 - Taylor & Francis
Infections due to multidrug-resistant Enterobacteriaceae have become major international
public health problem due to the inadequate treatment options and the historically lagged …

Treatment options for infections caused by carbapenem-resistant Enterobacteriaceae: can we apply “precision medicine” to antimicrobial chemotherapy?

F Perez, NG El Chakhtoura… - Expert opinion on …, 2016 - Taylor & Francis
Introduction: For the past three decades, carbapenems played a central role in our antibiotic
armamentarium, trusted to effectively treat infections caused by drug-resistant bacteria. The …

[HTML][HTML] Carbapenem-resistant Enterobacteriaceae: a menace to our most vulnerable patients

F Perez, D Van Duin - Cleveland Clinic journal of medicine, 2013 - ncbi.nlm.nih.gov
The emergence of carbapenem-resistant Enterobacteriaceae (CRE) highlights the
importance of effective antibiotics to maintain the safety of our health care system. Clinicians …